Mizuho Securities USA LLC Raises Holdings in TLGY Acquisition Co. (NASDAQ:TLGY)

Mizuho Securities USA LLC boosted its stake in TLGY Acquisition Co. (NASDAQ:TLGY) by 102.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 600,677 shares of the company’s stock after purchasing an additional 303,577 shares during the period. Mizuho Securities USA LLC owned about 6.34% of TLGY Acquisition worth $6,728,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of TLGY. Berkley W R Corp grew its holdings in shares of TLGY Acquisition by 71.0% in the first quarter. Berkley W R Corp now owns 479,609 shares of the company’s stock worth $5,420,000 after purchasing an additional 199,139 shares during the last quarter. Clear Street LLC bought a new stake in TLGY Acquisition in the 2nd quarter worth $62,000. K2 Principal Fund L.P. bought a new stake in TLGY Acquisition in the 2nd quarter worth $1,146,000. Spartan Fund Management Inc. increased its position in shares of TLGY Acquisition by 19,927.7% in the third quarter. Spartan Fund Management Inc. now owns 60,083 shares of the company’s stock valued at $693,000 after acquiring an additional 59,783 shares during the period. Finally, Wolverine Asset Management LLC raised its stake in shares of TLGY Acquisition by 0.9% during the third quarter. Wolverine Asset Management LLC now owns 365,828 shares of the company’s stock valued at $4,222,000 after acquiring an additional 3,098 shares during the last quarter. Institutional investors own 45.08% of the company’s stock.

TLGY Acquisition Price Performance

NASDAQ TLGY opened at $11.60 on Friday. TLGY Acquisition Co. has a 1 year low of $11.02 and a 1 year high of $11.60. The business’s 50-day moving average is $11.55 and its 200 day moving average is $11.49.

About TLGY Acquisition

TLGY Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. It intends to acquire companies in the biopharma or technology enabled business-to-consumer industries worldwide.